Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Change in Taxes (2016 - 2022)

Mimedx's Change in Taxes history spans 7 years, with the latest figure at -$52000.0 for Q4 2022.

  • For Q4 2022, Change in Taxes fell 144.07% year-over-year to -$52000.0; the TTM value through Dec 2022 reached -$39000.0, up 99.58%, while the annual FY2022 figure was -$39000.0, 99.58% up from the prior year.
  • Change in Taxes for Q4 2022 was -$52000.0 at Mimedx, up from -$53000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $10.7 million in Q1 2020 and bottomed at -$9.5 million in Q3 2021.
  • The 5-year median for Change in Taxes is $11000.0 (2018), against an average of $2400.0.
  • The largest annual shift saw Change in Taxes crashed 8350.0% in 2019 before it soared 89158.33% in 2020.
  • A 5-year view of Change in Taxes shows it stood at $10000.0 in 2018, then plummeted by 8350.0% to -$825000.0 in 2019, then rose by 2.06% to -$808000.0 in 2020, then surged by 114.6% to $118000.0 in 2021, then crashed by 144.07% to -$52000.0 in 2022.
  • Per Business Quant, the three most recent readings for MDXG's Change in Taxes are -$52000.0 (Q4 2022), -$53000.0 (Q3 2022), and $129000.0 (Q2 2022).